CatalystWireBeta

UK small-cap RNS · 3 Sep 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Key = all announcements except routine filings (voting rights, buybacks, holdings, director forms), plus the ones that are part of a situation. Not investment advice.

TimeCompanyMcap ↕TypeAnnouncement
16:00 Ninety One N91 £1,875m Insider conviction Director/PDMR Shareholding
15:59 Ferrexpo FXPO £341m Dilutive fundraise Proposed equity fundraise to raise US$100 million
Ferrexpo plc (LSE: FXPO), a producer and exporter of premium iron ore products, today announces its intention to launch an equity capital raise to raise gross proceeds of approximately US$100 million (the "Fundraise").
07:05 Futura Medical FUM £2.4m Sale process / strategic review Retail Offer via the BookBuild Platform
The Company is pleased to announce a retail offer via BookBuild to existing shareholders (the "Retail Offer") of up to 75,000,000 new ordinary shares of 0.2 pence each ("Ordinary Shares") in the capital of the Company (the "Retail Offer Shares") at an issue …
07:01 Renalytix RENX £40m Dilutive fundraise WRAP Retail Offer for up to £1,000,000
Renalytix is pleased to announce a retail offer via the Winterflood Retail Access Platform ("WRAP") to raise up to £1,000,000 (the "WRAP Retail Offer") through the issue of new ordinary shares of £0.0025 each in the capital of the Company (the "Ordinary …
07:00 Strategic Minerals SML £135m Disposal of a part (break-up) Leigh Creek – Sale Agreed
Layered consideration provides ongoing exposure to copper upside and supports reinvestment into Redmoor
07:00 Kazera Global KZG £17m Balance-sheet stress / refinancing Fujax Settlement, Proposed Fundraising & CAW
Fujax Settlement, Proposed Fundraising and Capital Access Window
07:00 Jadestone Energy JSE £241m Stake building towards control Holding(s) in Company
07:00 Renalytix RENX £40m Dilutive fundraise Result of Fundraise
Renalytix plc (LSE: RENX) (OTCQB: RNLXY), a precision medicine diagnostics company focussed on kidney disease, confirms that, further to the Company's announcement released at 7.01 a.m. on 1 September 2026 (RNS Number: 8254S) (the "Fundraising Announcement"), …
07:00 Tungsten West TUN £548m Project milestones Financial Results for the Year Ended 31 March 2026
Tungsten West (LON:TUN), the mining company focused on restarting production at the Hemerdon tungsten and tin mine ("Hemerdon" or the "Project") in Devon, UK, is pleased to announce its audited results for the year ended 31 March 2026 and the date of its …
07:00 Futura Medical FUM £2.4m Sale process / strategic review Fundraise and launch of FSP and M&A process
("Futura" or the "Company" and, together with its subsidiaries, the "Group")
07:00 EDX Medical Group Plc EDX £37m Project milestones Publication - Annual Report & Financial Statements
Launch of highly accurate early detection testing services for testicular and bowel cancer.
07:00 Brooks Macdonald Group BRK £234m Segment turn 2026 Full-year results
"Record FUMA, positive net flows and Brooks Financial demonstrating sustained momentum"
07:00 Hilton Food Group HFG £645m Upgrade / downgrade cycle Half-year Results
· Good performance from core meat and fresh prepared food, but Foppen weakness.
07:00 Crest Nicholson Holdings CRST £169m Upgrade / downgrade cycle Trading update
Trading Update on Positive Debt Reduction Progress and Revised FY26 Expectations
07:00 Camellia CAM £135m Project milestones Half-year Results
Half year results for the six months ended 30 June 2026
07:00 Synectics SNX £32m Upgrade / downgrade cycle £1.4m Award for UK Regional Authority
Ocular selected to provide advanced on-vehicle surveillance technology across 220 new buses

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note